Brief: Morphosys Updates Monjuvi U.S. Financial Guidance For 2023

Morphosys AG

25/10/2023 09:54

Oct 25 (Reuters) - MORPHOSYS AG  MORG.DE :
    * REPORTS PRELIMINARY Q3 2023 MONJUVI U.S. SALES AND GROSS
MARGIN,
AND UPDATES FINANCIAL GUIDANCE FOR 2023
    * ANTICIPATE FULL YEAR 2023 MONJUVI U.S. NET PRODUCT SALES
TO BE
US$ 85-95 MILLION AND FULL YEAR GROSS MARGIN FOR MONJUVI U.S.
NET PRODUCT SALES TO BE APPROXIMATELY 75%
    * PRELIMINARY Q3 2023 MONJUVI U.S. NET PRODUCT SALES OF US$
23.4
MILLION (EUR 21.5 MILLION)
    * PRELIMINARY GROSS MARGIN FOR MONJUVI U.S. NET PRODUCT
SALES FOR
Q3 2023 OF 65%

Source text for Eikon:  ID:nEQ20h6FXa 
Further company coverage:  MORG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))